MedPath

XYLOS CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Effectiveness of XCell on Autolytic Debridement of Venous Ulcers

Not Applicable
Completed
Conditions
Venous Ulcer
First Posted Date
2007-03-13
Last Posted Date
2007-03-13
Lead Sponsor
Xylos Corporation
Target Recruit Count
50
Registration Number
NCT00446823
Locations
🇺🇸

Boston University School of Medicine, Boston, Massachusetts, United States

🇺🇸

University Wound Care Center, Bronx, New York, United States

🇺🇸

Etris Associates, Philadelphia, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.